In addition, the combination of RT with IL-12/GM-CSF and anti-PD-L1 antibody enhanced tumor regression and accumulation of CD8+ T cells and tumor-associated neutrophils at the primary and metastatic site in vivo [200]. Here, CD8A is linked to neoplasm.